03:57

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared...

05:07

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lym...

05:10

Linvoseltamab can be a potentially effective treatment option for patients with relapsed/refract...

02:05

Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy...

02:53

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer

03:34

Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC

06:35

TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and ...

06:35

No benefit for adjuvant durvalumab in completely resected NSCLC

06:02

PFS increase but no OS increase for niraparib in advanced ovarian cancer

04:19

Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer

04:16

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

06:14

Neoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanoma

06:21

Faecal microbiota transplantation increases activity of immunotherapy in mRCC

03:11

Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma

04:15

Total neoadjuvant treatment without surgery for locally advanced rectal cancer

05:10

Study targets immunotherapy resistance pathways to tailor combination NSCLC therapy

03:24

Radiation therapy for breast cancer can be safely shortened

04:52

Cancer mutation prediction using AI

24:35

ESMO 2024: Highlights and analysis

02:09

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC

04:00

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer

08:59

Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectab...

03:16

Retifanlimab plus chemo shows PFS benefit in recurrent or metastatic squamous cell carcinoma of ...

03:34

Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS

05:32

Enzalutamide treatment boosted by Radium-223 in mCRPC

04:45

TACE combined with Len-Pem shows improved PFS in intermediate stage liver cancer

01:31

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

03:04

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nons...

03:06

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

04:21

Addition of relatlimab to nivolumab plus platinum-doublet chemotherapy demonstrates improved cli...

05:58

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE...

01:40

NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCC

03:03

Breastfeeding after breast cancer is safe

04:08

Nivolumab plus ipilimumab improves efficacy versus standard of care in non-clear-cell renal cell...

02:19

Repeat immune checkpoint inhibitor therapy not recommended for aRCC

04:58

Positive data for the use of radioligand therapy in first-line neuroendocrine cancers

04:54

Defining geriatric oncology

06:09

Revolving door between the regulators and industry

05:14

Perspectives on advance care planning for advanced cancer in the Philippines

05:43

The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant thera...

03:23

Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretrea...

07:06

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival ...

02:38

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeuti...

05:11

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advance...

05:13

Administering systemic chemotherapy improves survival for patients with resectable CRCLM

01:59

Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in ...

04:35

TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia

02:38

ATRA-ATO regimen with idarubicin could become the new standard of care in high-risk acute promye...

03:23

Novel CAR-T cell therapy shows promise against calreticulin mutant neoplasms

04:34

EHA 2024: Multiple myeloma roundup

03:27

Belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in RRMM compared to...

04:59

Ponatinib is better than imatinib for frontline treatment of newly diagnosed Ph+ acute lymphobla...

02:40

More effective treatment options required for patients with MM post lenalidomide exposure

04:10

Ibrutinib and venetoclax continue to provide benefits for patients with chronic CLL and SLL

05:23

Lower levels of inflammatory markers and tumour burden is linked to improvements in PFS with Ide...

02:29

Combination of zanubrutinib and venetoclax shows promise in high-risk TN CLL/SLL with del(17p) a...

06:26

Encouraging results using mismatched unrelated donors in stem cell transplantation

06:04

Immunotherapy significantly increases the number of patients free from bowel cancer

02:26

ARV-766 well tolerated and shows promising clinical activity in metastatic castration-resistant ...

02:32

Enfortumab vedotin improves efficacy outcomes in locally advanced or metastatic urothelial cance...